Human embryonic stem cell lines are contaminated: what should we do?

Area of Science:

• Stem cell biology
• Regenerative medicine
• Cell therapy

Background:

• Human embryonic stem (hES) cells offer potential for cell replacement therapies due to their differentiation capacity.
• Current hES cell lines are unsuitable for therapeutic use due to contamination with biological products.
• The presence of animal-derived components in hES cell culture poses a significant safety concern for clinical applications.

Purpose of the Study:

• To outline strategies for establishing the safest possible human embryonic stem cell lines for therapeutic purposes.
• To highlight the necessity of avoiding animal serum and feeder cells in hES cell line derivation.
• To propose safe and efficient methods for producing clinical-grade hES cells.

Main Methods:

• Review of recent advancements in human and animal stem cell research.
• Focus on developing animal-component-free (ACF) culture systems.
• Strategies for rigorous quality control and contamination assessment.

Main Results:

• Identified critical steps in hES cell establishment that require modification to ensure safety.
• Proposed specific protocols for serum-free and feeder-free hES cell culture.
• Demonstrated the feasibility of producing safer hES cell lines through updated methodologies.

Conclusions:

• Establishing animal-component-free human embryonic stem cell lines is crucial for safe cell replacement therapies.
• Recent scientific advances provide viable pathways for creating these essential therapeutic-grade stem cells.
• Further research and implementation of these safe methods will accelerate the clinical translation of hES cell-based treatments.